Thus in order to compare the effects of TrLp and CLp on GBM stem cells, we single-stained treated-GL261 cells with antibodies against the stem cell markers CD133 and SOX2 and performed flow cytometry analysis. This evidence concerns the gene SOX2 and glioblastoma.